ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
6,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
7,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11,1,Allogenic stem cell transplantation,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
11,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
14,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
14,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
15,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
16,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
16,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
16,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
16,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
16,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
16,7,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
17,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
17,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
18,1,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
18,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
18,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
19,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
19,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
20,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
20,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
20,5,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
20,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
20,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
22,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
23,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
24,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
24,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
24,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
25,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,2,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
25,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
25,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
26,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
27,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
27,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
27,3,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
27,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
28,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
30,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
31,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
33,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
33,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
35,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
36,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
36,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
37,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
38,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
39,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
39,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
39,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Blood thyroid stimulating hormone abnormal,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
40,2,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
41,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
42,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
43,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
44,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
44,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,4,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
44,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
44,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
44,7,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
44,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
44,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,11,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
45,1,Headache,Headaches NEC,Headaches,Nerv,N
46,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
47,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
47,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
47,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
48,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
48,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
48,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
48,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
49,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
49,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
49,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
49,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
49,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,9,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
49,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,12,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
50,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
50,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
50,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
52,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
52,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
52,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
53,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
54,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
56,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
57,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
58,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
58,3,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
59,1,Carcinoembryonic antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
59,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
60,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
61,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
62,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
62,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
64,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
64,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
65,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
66,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
67,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
67,2,Iatrogenic infection,Infectious transmissions,Ancillary infectious topics,Infec,N
67,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
67,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
67,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
68,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
68,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
69,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
70,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
71,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
72,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
72,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
73,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
74,3,Headache,Headaches NEC,Headaches,Nerv,N
74,4,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
75,1,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
75,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
76,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
76,2,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
77,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
78,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
79,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
80,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
81,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
81,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
81,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
82,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
82,2,Cardioversion,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
82,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
83,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
84,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
84,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
86,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
88,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
91,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
92,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
92,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
92,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
93,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
93,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
93,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
93,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
93,7,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
94,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
94,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,1,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,N
95,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
95,3,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
95,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
96,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
97,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
98,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
98,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
98,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
99,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
99,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
100,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
100,2,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
100,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
100,4,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
100,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
100,6,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
100,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
100,8,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
100,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
100,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
100,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
101,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
101,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
101,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
101,4,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
103,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
103,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
105,1,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
105,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
106,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
107,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
107,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
108,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
108,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
108,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
108,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
109,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
109,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
109,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
109,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,7,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
109,8,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
110,1,Autoimmune hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
110,2,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
110,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
111,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
111,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
111,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
111,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
111,5,Intestinal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
112,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
113,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
113,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
114,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
115,1,Chest tube insertion,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
115,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
115,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
115,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
115,5,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
115,6,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
116,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
118,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
118,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
119,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
119,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
120,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
120,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
120,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
122,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
123,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
125,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
126,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
127,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
127,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
127,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
127,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
127,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
127,6,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
127,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
128,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
128,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
129,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
130,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
131,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
132,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
133,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
134,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
135,1,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
135,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
135,3,Myopathy,Myopathies,Muscle disorders,Musc,N
136,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
136,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
137,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
137,2,Adrenalitis,Infections NEC,Infections - pathogen unspecified,Infec,N
137,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
138,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
139,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
140,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
140,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
140,3,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
140,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
141,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
141,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
142,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
145,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
145,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
145,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
145,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
146,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
147,1,Headache,Headaches NEC,Headaches,Nerv,N
148,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
148,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
149,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
149,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
150,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
151,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
151,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
152,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
152,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
152,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
153,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
153,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
154,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
155,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
155,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
155,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
156,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
156,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
156,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
156,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
156,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
158,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
158,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
158,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
158,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
159,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
160,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
161,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
162,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
163,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
163,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
163,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
163,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
164,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
165,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
166,1,Acne,Acnes,Skin appendage conditions,Skin,N
166,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
166,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
166,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
166,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
166,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
166,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
167,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
167,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
167,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
167,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
167,5,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
168,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
169,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
169,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
169,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
169,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
169,5,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
170,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
170,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
170,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
170,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
170,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
171,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
171,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
171,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
171,6,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
172,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
173,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
175,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
175,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
175,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
176,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
176,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
176,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
176,4,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
176,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
176,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
176,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
176,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
177,1,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
178,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
178,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
178,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
178,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
179,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
180,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
180,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
180,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
181,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
182,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
183,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
183,2,Headache,Headaches NEC,Headaches,Nerv,N
183,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
183,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
184,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
184,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
184,3,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
185,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
185,2,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
185,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
185,4,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
185,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
185,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
186,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
186,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
187,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
187,2,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
187,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
187,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
187,5,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
187,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
187,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
187,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
187,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,10,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
188,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
188,2,Thyroglobulin increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
189,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
189,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
189,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
189,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
190,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
190,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
191,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
192,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
193,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
193,2,Headache,Headaches NEC,Headaches,Nerv,N
193,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
193,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
194,2,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
195,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
195,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
196,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
197,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
197,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
198,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
198,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
198,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
198,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
199,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
200,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
201,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
201,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
201,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
201,4,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
202,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
203,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
203,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
203,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
204,1,Acquired amegakaryocytic thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
204,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
204,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
204,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
205,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
205,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
205,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
206,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
207,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
207,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
207,3,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
208,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
208,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
209,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
209,2,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
210,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
211,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
212,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
212,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
213,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
214,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
215,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
215,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
216,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
216,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
216,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
216,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
216,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
217,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
218,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
218,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,3,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
219,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
219,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
219,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
219,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
219,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
219,7,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
220,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
221,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
221,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
221,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
221,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
221,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
221,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
222,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
223,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
224,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
225,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
225,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
227,1,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
227,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
227,3,Phrenic nerve paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
228,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
229,1,Allergic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
229,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
229,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
230,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
230,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
230,3,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
231,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
231,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
231,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
232,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
233,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
234,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
234,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
235,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
235,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
235,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
235,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
236,1,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
236,2,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
237,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
237,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
237,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
238,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
239,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
240,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
240,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
240,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
241,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
242,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
243,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
243,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
243,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
243,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
244,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
244,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
246,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
246,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
246,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
246,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
248,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
249,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
249,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
249,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
249,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
249,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
249,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
250,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
251,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
251,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
251,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
253,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
253,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
253,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
254,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
255,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
256,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
257,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
257,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
257,5,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
258,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
258,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
258,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
259,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
260,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
261,1,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
261,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
262,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
262,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
262,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
263,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
263,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
263,3,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
263,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
264,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
264,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
264,3,Primary cerebellar degeneration,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
265,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
265,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
266,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
267,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
267,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
268,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
269,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
270,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
270,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
271,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
272,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
272,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
274,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
275,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
276,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
277,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
277,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
278,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
279,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
280,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
280,2,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
280,3,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
280,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
281,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
281,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
281,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
281,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
282,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,Y
283,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
283,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
283,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
284,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
285,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
286,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
286,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
286,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
286,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
286,5,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
286,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
286,7,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
286,8,Malignant splenic neoplasm,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
286,9,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
286,10,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
286,11,Metastases to breast,Metastases to specified sites,Metastases,Neopl,N
286,12,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
286,13,Metastases to stomach,Metastases to specified sites,Metastases,Neopl,N
286,14,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
286,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
286,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,17,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
286,18,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
286,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
287,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
287,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
288,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
288,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
288,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
288,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,5,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
288,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
289,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
290,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
290,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
290,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
291,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
291,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
291,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
291,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
292,1,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
292,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
292,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
292,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
292,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
292,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
294,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
295,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
296,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
296,2,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
296,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
296,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
296,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
296,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
297,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
298,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
299,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
299,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
299,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
300,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
301,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
301,2,Periorbital pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
302,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
303,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
304,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
304,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
304,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
305,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
306,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
306,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
306,3,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
306,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
306,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
307,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
307,2,Autoimmune myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
307,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
307,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
307,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
307,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
307,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
307,9,Trifascicular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
308,1,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
309,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
310,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
311,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
311,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
312,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
312,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
312,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,4,Headache,Headaches NEC,Headaches,Nerv,N
312,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
312,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
312,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
312,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
313,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
314,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
314,2,Autoimmune thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
314,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
314,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
315,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
315,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
315,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
315,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
315,5,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
316,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
317,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
318,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
318,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
318,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
319,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
320,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
321,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
321,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
322,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
322,2,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
322,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
323,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
324,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
325,1,Autoimmune thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
325,2,Myofascitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
326,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
326,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
326,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
326,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
326,5,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
326,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
326,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
326,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
326,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
326,10,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
326,11,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
326,12,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
327,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
327,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
328,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
328,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
330,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
330,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
330,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
330,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
330,5,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
330,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
330,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
330,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
330,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
330,10,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
330,11,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
330,12,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
330,13,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
331,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
331,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
333,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
334,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
335,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
335,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
335,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
336,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
336,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
336,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
336,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
337,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
337,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
337,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
337,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
337,5,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
337,6,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
338,1,Adrenalitis,Infections NEC,Infections - pathogen unspecified,Infec,N
338,2,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,N
338,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
338,4,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
339,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
340,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
340,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
340,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
340,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
340,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
340,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
340,8,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
341,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
341,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
341,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
341,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
341,5,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
341,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
341,7,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
341,8,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
341,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
341,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,13,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
341,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
341,15,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
342,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
343,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
343,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
343,4,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
343,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
345,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
346,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
346,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
346,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
346,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
346,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
346,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
346,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
346,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
347,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
348,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
348,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
348,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
348,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
348,5,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
349,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
350,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
351,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
351,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
351,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
351,4,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
351,5,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
351,6,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
351,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
352,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
352,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
352,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
353,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
353,2,Lip erosion,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
353,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
353,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
354,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
355,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
355,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
355,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
357,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
357,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
357,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
357,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
357,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
358,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
358,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
358,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
358,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
358,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
358,6,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
358,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
358,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
358,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
359,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
360,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
360,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
360,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
360,4,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
361,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
362,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
363,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
363,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
363,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
363,4,Headache,Headaches NEC,Headaches,Nerv,N
363,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
364,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
365,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
365,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
365,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
365,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
365,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
365,6,Headache,Headaches NEC,Headaches,Nerv,N
365,7,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
365,8,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
365,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
365,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
365,11,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
365,12,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
365,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
366,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
366,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
367,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
367,2,Herpes simplex test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
367,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
367,4,Leptospirosis,Leptospira infections,Bacterial infectious disorders,Infec,N
367,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
367,6,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
368,1,Headache,Headaches NEC,Headaches,Nerv,N
369,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
370,1,Headache,Headaches NEC,Headaches,Nerv,N
371,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
371,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
372,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
373,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
374,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
374,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
374,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
374,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
374,5,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
374,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
374,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
375,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
375,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
376,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
376,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
376,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
376,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
376,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
376,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
376,7,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
377,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
377,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
377,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
377,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
377,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
378,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
378,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
378,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
378,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
379,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
379,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
379,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
379,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
380,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
380,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
380,3,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
380,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
381,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
382,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
382,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
383,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
383,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
383,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
384,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
385,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
385,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
386,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
387,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
387,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
388,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
388,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
388,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
388,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
389,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
389,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
390,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
390,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
391,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
392,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
392,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
392,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
392,4,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
393,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
393,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
393,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
395,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
395,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
396,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
397,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
397,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
397,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
397,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
397,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
398,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
398,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
398,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
398,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
399,1,Autoimmune uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
399,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
400,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
401,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
401,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
402,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
403,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
404,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
405,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
405,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
405,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
405,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
405,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
406,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
406,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
407,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
407,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
407,3,Headache,Headaches NEC,Headaches,Nerv,N
407,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
407,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
408,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
409,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
409,2,Fulminant type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
409,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
410,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
411,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
411,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
411,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
411,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
411,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
412,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
413,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
413,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
414,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
415,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
415,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
415,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
416,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
416,2,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
417,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
417,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
418,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
418,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
419,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
419,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
419,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
420,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
421,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
421,2,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
422,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
422,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
422,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
423,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
423,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
423,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
423,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
423,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
424,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
425,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
425,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
426,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
426,2,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
426,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
426,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
426,5,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
427,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
428,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
428,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
428,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
428,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
429,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
429,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
429,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
429,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
429,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
429,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
429,7,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
429,8,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
429,9,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
429,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
429,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
429,12,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
430,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
431,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
431,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
432,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
433,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
434,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
434,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
434,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
434,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
435,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
435,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
435,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
435,4,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
436,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
436,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
436,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
437,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
438,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
438,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
438,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
439,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
439,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
439,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
439,4,Headache,Headaches NEC,Headaches,Nerv,N
439,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
439,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
440,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
440,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
440,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
441,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
442,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
442,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
442,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
442,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
442,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
442,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
444,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
445,1,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
445,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
446,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
447,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
447,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
447,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
448,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
449,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
449,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
449,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
449,4,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
449,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
449,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
450,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
451,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
451,2,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,N
452,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
452,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
453,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
453,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
453,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
454,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
455,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
455,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
455,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
455,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
455,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
455,6,Headache,Headaches NEC,Headaches,Nerv,N
456,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
457,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
457,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
457,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
457,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
457,5,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
458,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
459,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
460,1,Accelerated hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
460,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
460,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
461,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
461,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
462,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
462,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
462,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
462,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
462,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
462,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
462,7,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
462,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
462,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
462,10,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
462,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
462,12,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
462,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
463,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
464,1,Hypercalcaemia of malignancy,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
465,1,Hypercalcaemia of malignancy,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
465,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
466,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
467,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
467,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
467,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
467,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
468,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
468,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
469,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
469,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
469,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
470,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
470,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
470,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
471,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
471,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
471,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
472,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
472,2,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
472,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
473,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
473,2,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
474,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
474,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
474,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
474,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
474,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
475,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
476,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
476,2,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
477,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
477,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
478,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
478,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
479,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
479,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
479,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
479,4,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
479,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
479,6,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
480,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
480,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
481,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
482,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
482,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
483,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
484,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
484,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
485,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
486,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
486,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
486,3,Lymphocytic hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
487,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
487,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
488,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
489,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
489,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
490,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
491,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
491,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
492,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
492,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
492,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
493,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
494,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
494,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
495,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
495,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
496,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
496,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
496,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
496,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
496,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
496,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
496,7,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
496,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
496,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
496,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
497,1,Pneumocystis test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
497,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
498,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
498,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
498,3,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
498,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
499,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
499,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
499,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
500,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
500,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
501,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
501,2,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
502,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
502,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
503,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
503,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
503,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
504,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
504,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
505,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
505,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
506,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
506,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
506,4,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
507,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
507,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
507,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
508,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
508,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
508,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
508,4,Nephritis,Nephritis NEC,Nephropathies,Renal,N
508,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
508,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
510,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
511,1,Autoimmune arthritis,Arthropathies NEC,Joint disorders,Musc,N
511,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
512,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
512,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
512,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
513,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
513,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
513,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
513,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
514,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
515,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
515,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
515,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
516,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
517,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
517,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
517,3,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
517,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
517,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
517,6,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
517,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
517,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
517,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
517,10,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
517,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
517,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
518,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
519,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
519,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
519,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
519,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
520,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
520,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
520,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
520,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
520,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,6,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
521,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
521,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
521,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
521,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
522,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
522,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
523,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
525,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
526,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
527,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
528,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
529,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
530,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
531,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
531,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
531,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
532,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
532,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
532,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
533,1,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
534,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
534,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
534,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
534,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
534,5,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
534,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
534,7,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
535,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
535,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
535,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
535,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
535,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
536,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
537,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
538,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
539,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
540,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
541,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
541,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
541,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
541,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
542,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
542,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
543,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
543,2,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
543,3,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
544,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
544,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
544,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
545,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
545,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
546,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
546,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
547,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
548,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
548,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
548,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
549,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
549,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
549,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
549,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
549,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
549,6,Headache,Headaches NEC,Headaches,Nerv,N
549,7,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
549,8,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
549,9,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
549,10,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
549,11,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
549,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
550,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
551,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
552,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
553,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
554,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
555,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
555,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
556,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
557,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
558,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
559,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
560,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
560,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
561,1,Autoimmune inner ear disease,Inner ear infections and inflammations,Inner ear and VIIIth cranial nerve disorders,Ear,N
561,2,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
561,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
561,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
561,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
561,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
561,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
562,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
563,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
563,2,Vitreoretinal traction syndrome,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
564,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
564,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
564,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
564,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
564,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
565,1,Deafness,Hearing losses,Hearing disorders,Ear,N
565,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
565,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
566,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
566,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
566,3,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
566,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
566,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
566,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
566,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
567,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
568,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
568,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
568,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
568,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
569,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
569,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
569,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
569,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
570,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
571,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
571,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
571,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
572,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
573,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
573,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
574,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
575,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
575,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
575,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
576,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
576,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
576,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
577,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
578,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
578,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
578,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
578,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
578,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
578,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
579,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
580,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
580,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
580,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
581,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
582,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
582,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
583,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
583,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
583,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
583,4,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
583,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
584,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
584,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
585,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
586,1,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
587,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
587,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
587,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
588,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
588,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
588,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
589,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
589,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
589,3,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
590,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
591,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
592,1,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
592,2,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
593,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
593,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
594,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
594,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
595,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
596,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
596,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
596,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
596,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
597,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
597,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
598,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
598,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
598,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
598,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
599,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
600,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
600,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
601,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
601,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
602,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
603,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
603,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
604,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
605,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
605,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
605,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
606,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
606,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
607,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
608,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
609,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
609,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
610,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
610,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
610,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
610,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
611,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
611,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
611,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
611,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
612,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
612,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
612,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
612,4,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
613,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
613,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
613,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
613,4,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
614,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
615,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
615,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
615,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
615,4,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
616,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
616,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
617,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
618,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
618,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
619,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
620,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
621,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
622,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
622,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
623,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
624,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
625,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
626,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
628,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
628,2,Sialoadenitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
629,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
630,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
631,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
632,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
632,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
633,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
633,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
633,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
633,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
634,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
634,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
635,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
635,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
636,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
637,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
637,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
637,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
638,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
638,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
639,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
640,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
641,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
641,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
642,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
642,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
643,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
643,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
643,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
643,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
643,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
644,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
645,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
646,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
647,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
647,2,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
647,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
647,4,Headache,Headaches NEC,Headaches,Nerv,N
647,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
647,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
647,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
648,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
648,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
649,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
650,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
651,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
651,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
651,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
651,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
652,1,Gastric mucosal lesion,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
652,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
652,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
653,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
654,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
655,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
655,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
655,3,Headache,Headaches NEC,Headaches,Nerv,N
656,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
657,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
658,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
659,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
659,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
660,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
660,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
660,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
661,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
662,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
662,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
663,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
663,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
663,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
664,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
665,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
665,2,Pleural disorder,Pleural conditions NEC,Pleural disorders,Resp,N
666,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
666,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
666,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
666,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
667,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
668,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
668,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
668,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
668,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
668,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
668,6,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
668,7,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
668,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
668,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
668,10,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
668,11,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
668,12,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
669,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
670,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
670,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
670,3,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
670,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
671,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
672,1,Melanosis,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
673,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
673,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
674,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
674,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
675,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
675,2,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
675,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
675,4,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
675,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
675,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
675,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
675,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
675,9,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
675,10,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
676,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
677,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
677,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
678,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
679,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
679,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
679,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
679,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
680,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
680,2,Jejunal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
680,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
681,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
682,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
682,2,Immune-mediated encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
682,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
682,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
682,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
682,6,Toxic leukoencephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
683,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
683,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
683,3,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
684,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
684,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
684,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
685,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
685,2,Salivary gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
686,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
686,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
687,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
688,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
688,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
688,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
689,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
689,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
690,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
690,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
691,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
692,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
692,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
693,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
693,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
694,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
694,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
694,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
694,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
695,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
696,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
696,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
696,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
696,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
697,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
697,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
698,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
699,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
699,2,Increased viscosity of upper respiratory secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
699,3,Nasal mucosal discolouration,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
699,4,Sinonasal obstruction,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
699,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
700,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
700,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
700,3,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
700,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
700,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
700,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
701,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
701,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
701,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
701,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
701,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
702,1,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
702,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
703,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
703,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
703,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
704,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
704,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
705,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
706,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
706,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
707,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
708,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
709,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
709,2,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
710,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
711,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
712,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
712,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
713,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
713,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
714,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
714,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
715,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
715,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
715,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
715,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
716,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
716,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
717,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
717,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
717,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
718,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
718,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
718,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
718,4,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
719,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
719,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
720,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
720,2,Headache,Headaches NEC,Headaches,Nerv,N
720,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
720,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
720,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
721,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
721,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
722,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
723,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
723,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
724,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
724,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
724,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
724,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
725,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
725,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
726,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
726,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
726,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
726,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
727,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
727,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
727,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
728,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
728,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
729,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
730,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
731,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
731,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
731,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
731,4,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
731,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
732,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
733,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
734,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
734,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
735,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
736,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
737,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
737,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
737,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
737,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
738,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
738,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
739,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
739,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
740,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
741,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
741,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
741,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
741,4,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
741,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
742,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
742,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
742,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
742,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
742,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
743,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
743,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
743,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
744,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
744,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
744,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
744,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
744,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
744,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
744,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
744,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
745,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
745,3,Fulminant type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
745,4,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
746,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
746,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
747,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
747,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
748,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
749,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
749,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
749,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
750,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
751,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
752,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
752,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
752,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
753,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
754,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
755,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
756,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
756,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
756,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
757,1,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
758,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
759,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
759,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
760,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
760,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
760,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
760,4,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
761,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
762,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
763,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
763,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
763,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
764,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
765,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
765,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
766,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
766,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
767,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
767,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
767,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
767,4,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
768,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
768,2,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
769,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
769,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
770,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
770,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
771,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
772,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
773,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
773,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
774,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
775,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
776,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
776,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
777,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
778,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
778,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
778,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
779,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
780,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
780,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
780,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
781,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
781,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
782,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
783,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
783,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
783,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
784,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
784,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
784,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
785,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
786,1,Lichen planopilaris,Alopecias,Skin appendage conditions,Skin,N
787,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
788,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
788,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
789,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
790,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
791,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
792,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
792,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
793,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
793,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
793,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
793,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
793,5,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
794,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
795,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
795,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
796,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
797,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
797,2,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
797,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
798,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
799,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
799,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
800,1,Intratumoural haematoma,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
801,1,Intratumoural haematoma,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
801,2,Intratumoural haematoma,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
801,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
802,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
802,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
802,3,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
803,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
803,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
803,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
803,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
803,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
804,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
804,2,Intratumoural haematoma,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
804,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
805,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
805,2,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
805,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
806,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
806,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
806,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
807,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
807,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
807,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
808,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
808,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
808,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
809,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
809,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
809,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
810,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
810,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
811,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
811,2,Ocular ischaemic syndrome,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
811,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
812,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
813,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
813,2,Retinal melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
814,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
814,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
815,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
816,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
817,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
817,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
817,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
817,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
817,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
817,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
818,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
818,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
818,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
818,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
818,5,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
818,6,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
818,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
818,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
818,9,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
818,10,Stoma site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
818,11,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
819,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
819,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
819,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
820,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
821,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
821,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
822,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
822,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
822,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
823,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
823,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
824,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
825,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
825,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
826,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
826,2,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
826,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
826,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
826,5,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
827,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
828,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
828,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
829,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
830,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
831,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
831,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
832,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
833,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
833,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
833,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
833,4,Headache,Headaches NEC,Headaches,Nerv,N
833,5,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
833,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
834,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
835,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
836,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
837,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
838,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
839,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
839,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
839,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
840,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
841,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
842,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
842,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
843,1,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
843,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
844,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
845,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
845,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
845,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
845,4,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
845,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
845,6,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
846,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
846,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
847,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
848,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
848,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
848,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
848,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
848,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
848,6,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
848,7,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
848,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
848,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
848,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
848,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
848,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
848,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,14,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
848,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
848,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
848,17,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
849,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
849,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
849,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
850,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
851,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
851,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
852,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
853,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
853,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
854,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
854,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
856,1,Lymphocytic hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
857,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
857,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
858,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
859,1,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
860,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
860,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
861,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
862,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
862,2,Oesophageal achalasia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
863,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
864,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
865,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
865,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
865,3,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
865,4,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
866,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
867,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
868,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
869,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
869,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
870,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
870,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
871,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
872,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
872,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
872,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
872,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
872,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
872,6,Scrotal abscess,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
872,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
873,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
874,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
875,1,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
876,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
876,2,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
877,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
877,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
878,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
879,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
880,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
881,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
882,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
882,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
882,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
882,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
882,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
882,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
882,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
883,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
884,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
884,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
884,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
884,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
884,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
884,6,Paraneoplastic encephalomyelitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
884,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
885,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
886,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
886,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
886,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
887,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
888,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
888,2,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
888,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
888,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
888,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
888,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
889,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
890,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
891,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
892,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
893,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
894,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
895,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
896,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
897,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
898,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
899,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
900,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
901,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
902,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
903,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
904,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
905,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
906,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
907,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
908,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
909,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
910,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
911,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
912,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
913,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
914,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
915,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
916,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
917,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
918,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
919,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
920,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
921,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
922,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
923,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
924,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
925,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
926,1,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
926,2,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,Y
927,1,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
928,1,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
929,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
930,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
931,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
932,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
933,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
933,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
934,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
934,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
935,1,Renal cell carcinoma recurrent,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
936,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
936,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
937,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
937,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
937,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
938,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
939,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
939,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
939,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
940,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
940,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
941,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
941,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
941,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
941,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
941,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
942,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
942,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
942,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
943,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
943,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
944,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
944,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
945,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
945,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
945,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
945,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
945,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
945,6,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
945,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
945,8,Gingival abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
945,9,Headache,Headaches NEC,Headaches,Nerv,N
945,10,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
945,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
945,12,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
945,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
945,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
945,15,Rheumatic disorder,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
945,16,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
946,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
946,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
946,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
947,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
947,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
948,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
948,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
949,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
949,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
949,3,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
950,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
950,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
950,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
951,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
951,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
951,3,Nephritis,Nephritis NEC,Nephropathies,Renal,N
951,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
952,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
953,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
953,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
954,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
954,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
955,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
955,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
955,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
956,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
956,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
957,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
957,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
958,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
958,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
958,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
959,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
959,2,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
959,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
959,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
959,5,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
960,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
960,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
961,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
961,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
962,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
962,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
962,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
962,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
962,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
963,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
963,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
963,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
963,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
963,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
964,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
965,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
966,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
967,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
967,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
967,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
967,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
967,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
967,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
967,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
967,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
969,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
969,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
970,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
970,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
970,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
970,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
971,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
971,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
972,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
972,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
972,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
972,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
972,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
973,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
974,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
975,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
976,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
977,1,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
977,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
977,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
977,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
977,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
977,6,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
977,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
978,1,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
978,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
979,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
979,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
980,1,Immune-mediated arthritis,Arthropathies NEC,Joint disorders,Musc,N
980,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
980,3,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
980,4,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
981,1,Acquired epidermolysis bullosa,Bullous conditions,Epidermal and dermal conditions,Skin,N
981,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
982,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
983,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
983,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
983,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
983,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
983,5,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
983,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
984,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
984,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
985,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
986,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
987,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
988,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
988,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
988,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
988,4,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
988,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
988,6,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
988,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
988,8,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
989,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
990,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
990,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
990,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
990,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
990,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
990,6,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
991,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
992,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
992,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
992,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
993,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
994,1,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
995,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
995,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
996,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
996,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
996,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
997,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
998,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
998,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
999,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1000,1,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1001,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1002,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1003,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1004,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1005,1,Metastases to kidney,Metastases to specified sites,Metastases,Neopl,N
1006,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1007,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1007,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1008,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1009,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1009,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1009,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1010,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1011,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1012,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1012,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1012,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1012,4,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
1013,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1013,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1014,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1015,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1016,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1016,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1016,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1016,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1016,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1016,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1016,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1016,8,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1016,9,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1016,10,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1016,11,Thyroxine free decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1017,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1017,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1017,3,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1017,4,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1017,5,Hyperadrenocorticism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1017,6,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1017,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1017,8,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1017,9,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
1017,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1018,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1018,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1018,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1018,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1019,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1020,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1020,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1020,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1020,4,Headache,Headaches NEC,Headaches,Nerv,N
1020,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1020,6,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1020,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1020,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1020,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1020,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1020,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1020,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1020,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1021,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1021,2,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1022,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1022,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1022,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1022,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1022,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1022,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1023,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1023,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1024,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1024,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1025,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1025,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1026,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1027,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1027,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1028,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1029,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1030,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1030,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1031,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1032,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1032,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1033,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1033,2,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
1033,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1033,4,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1033,5,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
1033,6,Post procedural pulmonary embolism,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1033,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1034,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1035,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1035,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1036,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1037,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1038,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1039,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1039,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1039,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1039,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1039,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1040,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1040,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1040,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1040,4,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1040,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1040,6,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
1041,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1042,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1042,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1042,3,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
1042,4,Post procedural fever,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1042,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1042,6,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1043,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1043,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1043,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1043,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1043,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1044,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1044,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1044,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1045,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1046,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1047,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1048,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1049,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1049,2,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1049,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1049,4,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1049,5,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1049,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1049,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1049,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1049,9,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1050,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1050,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1051,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1052,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1053,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1054,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1055,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1055,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1056,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1057,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1058,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1059,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1060,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1060,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1061,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1062,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1062,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1062,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1063,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1064,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1064,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1065,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1065,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1066,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1066,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1067,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1068,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1069,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1070,1,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
1070,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1071,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1072,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1073,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1073,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1074,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1075,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1076,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1077,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1078,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1079,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1079,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1080,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1081,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1081,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1081,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1082,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1083,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1083,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1084,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1085,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1086,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1087,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1088,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1089,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1090,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1091,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1092,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1093,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1093,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1093,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1093,4,Immunochemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
1093,5,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1093,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1094,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1095,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1095,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1096,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1096,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1097,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1097,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1097,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1098,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1099,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1100,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1100,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1100,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1101,1,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1102,1,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1103,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1103,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1104,1,Dependence on respirator,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1104,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1104,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1104,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1104,5,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1104,6,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1104,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1104,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1105,1,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1106,1,Epilepsia partialis continua,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,N
1107,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1108,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1108,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1108,3,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1108,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1108,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1109,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1109,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1110,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1110,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1111,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
1111,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
1111,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1111,4,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1112,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1112,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1113,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1113,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1114,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1115,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1116,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1117,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1118,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1119,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1120,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1121,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1122,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1122,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1122,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1123,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
1123,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1123,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1123,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1123,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1123,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1123,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1123,8,Headache,Headaches NEC,Headaches,Nerv,N
1124,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1125,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1126,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1127,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1128,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1129,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1129,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1130,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1130,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1130,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1130,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1130,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1130,6,Oscillopsia,Visual disorders NEC,Vision disorders,Eye,N
1131,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1131,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1131,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1131,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1131,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1131,6,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1131,7,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1131,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1132,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1132,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1132,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1133,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1134,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1135,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1136,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1136,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1136,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1137,1,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1137,2,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1138,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1138,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1139,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1140,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1140,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1140,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1140,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1141,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1141,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1141,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1142,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1142,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1142,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1143,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1143,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1144,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1145,1,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1145,2,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1145,3,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1146,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1146,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1147,1,Enterovesical fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1147,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1147,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1148,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
1149,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1149,2,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1149,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1149,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1149,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1149,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,7,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1149,8,Urinary tract infection enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
1149,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1150,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1151,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1152,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1152,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1152,3,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1152,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1152,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1153,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1153,2,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1154,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1155,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1155,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1155,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1155,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1155,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1155,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1156,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1156,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1157,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1158,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1159,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1160,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1161,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1161,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
1161,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1162,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1162,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1162,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1162,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1162,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1163,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1164,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1164,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1164,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1164,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1165,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1165,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1165,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
1165,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1165,5,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1166,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1167,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1168,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1169,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1169,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1169,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1169,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1169,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1169,6,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1169,7,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1169,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1170,1,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1171,1,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1172,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1172,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1173,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1174,1,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1174,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1175,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1176,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1176,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1176,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1177,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1177,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1177,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1177,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1177,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1177,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1177,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1178,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
1179,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1180,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1181,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1181,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1181,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1181,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1181,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1181,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1181,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1182,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1182,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1182,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1182,4,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
1182,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1182,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1182,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1182,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1183,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1184,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1184,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1185,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1186,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1186,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1187,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1187,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1187,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1187,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1188,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1188,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1188,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1189,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1189,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1190,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1190,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1191,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1191,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1192,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1193,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
1193,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1193,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1193,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1194,1,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1194,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1194,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1195,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1195,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
1195,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1195,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1196,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1196,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1196,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1197,1,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1197,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1197,3,Immune-mediated hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1198,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1199,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1199,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1199,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1199,4,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
1200,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1200,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1200,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1200,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1200,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1201,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1202,1,Headache,Headaches NEC,Headaches,Nerv,N
1203,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1203,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1203,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1203,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1203,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1203,6,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
1203,7,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1203,8,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1203,9,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1203,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1203,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1203,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1203,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1204,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1205,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1205,2,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1205,3,Malignant neoplasm oligoprogression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1205,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1206,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1206,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1207,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1207,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1208,1,Ascending flaccid paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1208,2,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1208,3,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1208,4,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,Y
1208,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1208,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1209,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1210,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1211,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1211,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1212,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1212,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1212,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1213,1,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1214,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1215,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1215,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1216,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1217,1,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1218,1,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1219,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1220,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1220,2,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1220,3,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1220,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1220,5,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1221,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1221,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1221,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1222,1,Headache,Headaches NEC,Headaches,Nerv,N
1222,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1223,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1223,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1223,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1224,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1225,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1226,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1226,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1227,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1227,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1227,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1227,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1227,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1227,6,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1227,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1227,8,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1228,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1229,1,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
1230,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1230,2,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1230,3,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1230,4,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1231,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1232,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1233,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1233,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1233,3,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1234,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1235,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1235,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1236,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1237,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1237,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1237,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1237,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1237,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1237,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1237,7,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1237,8,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1237,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1237,10,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1237,11,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1237,12,Migraine,Migraine headaches,Headaches,Nerv,N
1237,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1237,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1237,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1237,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1237,17,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1238,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1238,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1238,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1238,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1238,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1238,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1238,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1239,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1240,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1241,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1242,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1243,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1244,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1244,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1244,3,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
1244,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
